ACT Capital Management »

Cerebras Systems shares owned by ACT Capital Management

Quarter-by-quarter ownership of Cerebras Systems (CBRS) shares owned by ACT Capital Management from 13F filings

Historical chart of ACT Capital Management investment in Cerebras Systems

Tip: Access up to 7 years of quarterly data

All positions including Cerebras Systems held by ACT Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerebras Systems by ACT Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.2M 5.6k 221.00

More positions owned by ACT Capital Management

Krystal Biotech (KRYS)
Tg Therapeutics (TGTX)
Abivax Sa Sponsored Ads (ABVX)
Chevron Corporation (CVX)
Exxon Mobil Corporation (XOM)
Arrowhead Pharmaceuticals (ARWR)
Viking Therapeutics (VKTX)
Celcuity (CELC)
Nektar Therapeutics Com New (NKTR)
Tesla Motors (TSLA)
Cytokinetics (CYTK)
Ast Spacemobile Com Cl A (ASTS)
Palvella Therapeutics Inc Ne (PVLA)
Amazon (AMZN)
Nuvation Bio Com Cl A (NUVB)

View all positions for ACT Capital Management

Top funds holding Cerebras Systems

Sumitomo Mitsui Trust Holdings
Hamilton Lane Advisors
Belvedere Trading
Walleye Trading
Brown University
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet
Ofi Invest Asset Management
Walleye Trading Advisors
Davy Asset Management
SAM Sustainable Asset Management
Ardsley Advisory Partners
CenterStar Asset Management
TD Asset Management
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet
DekaBank Deutsche Girozentrale

View all funds holding Cerebras Systems